Hepatitis C virus: Epidemiology and transmission

Hepatology

Volumn 26, Issue 3, 1997, Pages 521-526

  Heintges, Tobias ^a   Wands, Jack R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER DISEASE; BLOOD DONOR; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; NEEDLESTICK INJURY; PERINATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0030752667     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260338     Document Type: Review

References (95)

1. Heintges T, Niederau C. Epidemiologie und Klinik der chronischen Virushepatitis. Dtsch Med Wschr 1994;119:1365-1370.
2. Gutensohn K, Knödler B, Zeller W, Krüger W, Eckardt N, Hossfeld D-K, Kühnl P. Prävalenz des Hepatitis-C-Virus bei polytransfundierten Patienten mit hämatologischen und onkologischen Erkrankungen. Infusionstherapie 1992;19:19-22.
3. Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-373.
4. Schreiber GB, Busch MP, Kleinmann SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
5. Flora K, Schiele M, Benner K, Montanaro A, Johnston W, Witham R, Press R An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin. Ann Allergy Asthma Immunol 1996;76:160-162.
6. Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap P-L, Fleming KA, Chapman RWG, et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 1996;110:1120-1126.
7. Yu MY, Mason BL, Tanmkersley DL. Detection and characterization of hepatitis C virus RNA in immune globulines. Transfusion 1994;34:596-602.
8. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with contaminated immune globulin. N Engl J Med 1994; 331:1607-1611.
9. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-1213.
10. Meisel H, Reip A, Faltus B, Lu M, Porst H, Wiese M, Roggendorf M, Kruger DH. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 1995;345:1209-1211.
11. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994;106:1596-1602.
12. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, Galanti C, et al. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995;27:441-444.
13. Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Kawakami Y, Akazawa K, Kashiwagi S. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995;90:794-799.
14. Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, Hall JE, et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993;67: 4365-4368.
15. Kurauchi O, Furui T, Itakura A, Ishiko H, Sugiyama M, Ohno Y, Ando H, et al. Studies on transmission of hepatitis C virus from mother-to-child in the perinatal period. Arch Gynecol Obstet 1993;253:121-126.
16. Silverman AL, Puccio JE, Kulesza GW, McCray DG, Gordon SC. HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am J Gastroenterol 1994;89:1201-1202.
17. Moriya T, Sasaki F, Mizui M, Ohno N, Mohri H, Mishiro S, Yoshizawa H. Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomed Pharmacother 1995;49:59-64.
18. Paccagnini S, Principi N, Massironi E, Tanzi E, Romano L, Muggiasca ML, Ragni MC, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995; 14:195-199.
19. Roudot-Thoraval F, Pawlotsky JM, Thiers V, Deforges L, Girollet PP, Guillot F, Huraux C, et al. Lack of mother-to-infant transmission of hepatitis C virus in HIV-seronegative women: a prospective study with hepatitis C virus RNA testing. HEPATOLOGY 1993;17:772-777.
20. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D'Amico E, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on vertical HCV transmission. Lancet 1995; 345:289-291.
21. Silverman NS, Snyder M, Hodinka RL, McMillen P, Knee G. Detection of hepatitis C virus antibodies and specific hepatitis C virus ribonucleic acid sequences in cord bloods from a heterogeneous prenatal population. Am J Obstet Gynecol 1995;173:1396-1400.
22. Lin HH, Kao JH, Hsu HY, Chang MH, Huang SC, Hwang LH, Huang SC, et al. Absence of infection in breast-fed infants born to hepatitis C virus infected mothers. J Pediatr 1995;126:589-591.
23. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, Non-A, Non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. HEPATOLOGY 1990;12:671-675.
24. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 1995;23:273-277.
25. Gordon SC, Patel AH, Kulesza GW, Barnes RE, Silverman AL. Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 1992;87:1849-1851.
26. Soto B, Rodrigo L, Garcia-Bengoechea M, Sanchez-Quijano A, Riestra S, Arenas JI, Andreu J, et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings. J Intern Med 1994;236:515-519.
27. Chang TT, Liou KC, Young KC, Lin XZ, Lin CY, Shin JS, Wu HL. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994;42:91-96.
28. Chayama K, Kobayashi M, Tsubota A, Koida I, Arase Y, Saitoh S, Ikeda K, et al. Molecular analysis of intraspousal transmission of hepatitis C virus. J Hepatol 1995;22:431-439.
29. Nakashima S, Ikematsu H, Hayashi J, Kishihara Y, Mutsutake A, Kashiwagi S. Intrafamilial transmission of hepatitis C virus among the population of an endemic area in Japan. JAMA 1995;274:1459-1461.
30. Fried MW, Shindo M, Fong T-S, Fox PC, Hoofnagle JH, di Bisceglie AM. Absence of hepatitis C viral RNA from saliva and semen in patients with chronic hepatitis C. Gastroenterology 1992;102:1306-1308.
31. Hsu HH, Wright TL, Luba D, Martin M, Feinstone SM, Garcia G, Greenberg HB. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. HEPATOLOGY 1991;14: 763-767.
32. Wang JT, Wang TH, Sheu JC, Lin JT, Chen DS. Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses. J Med Virol 1992;36:28-31.
33. Hyams KC, Phillips IA, Tejada A, Wignall FS, Roberts CR, Escamilla J. Three-year incidence study of retroviral and viral hepatitis transmission in a Peruvian prostitute population. J Acquir Immune Defic Syndr 1993; 6:1353-1357.
34. Lissen E, Alter HJ, Abad MA, Torres Y, Perez-Romereo M, Leal M, Pineda JA. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis 1993;12:827-831.
35. Wu JC, Lin HC, Jeng FS, Ma GY, Lee SD, Sheng WY. Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes. J Med Virol 1993;39:312-317.
36. Melbye M, Biggar RJ, Wantzin P, Krogsgaard K, Ebbesen P, Becker NG. Sexual transmission of hepatitis C virus: a cohort study (1981-9) among European homosexual men. Br Med J 1990;301:210-212.
37. Alter MJ. Epidemiology of hepatitis C in the west. Sem Liver Dis 1995; 15:5-14.
38. Aymard JP, Botte C, Contal P, Janot C, Treiff F. Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers. Pathol Biol Paris 1993; 41:149-153.
39. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000.
40. Mutimer DJ, Harrison RF, O'Donell KB, Shaw J, Martin BA, Atrah H, Ala FA, et al. Hepatitis C virus infection in the asymptomatic British blood donor. J Viral Hepat 1995;2:47-53.
41. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Leiner DE, Tedeschi V, Krawczynski K, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995;123:330-337.
42. Suwanagool S, Tieangrim S, Ratasanuwan W, Mekanantangosol S, Luengrojanakul P, Kunasol P. Seroprevalence of anti-HCV-infected persons and general population. J Med Assoc Thailand 1995;78:611-617.
43. Irshad M, Archarya SK, Joshi YK. Prevalence of hepatitis C virus antibodies in the general population & in selected groups of patients in Delhi. Indian J Med Res 1995;102:162-164.
44. Duraisamy G, Zuridah H, Ariffin MY. Prevalence of hepatitis C virus antibodies in blood donors in Malaysia. Med J Malaysia 1993;48:313-316.
45. al-Faleh FZ, Ramia S, Arif M, Ayoola EA, al-Rashed RS, al-Jeffry M, Hossain A, et al. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan areas of Saudi Arabia: a community-based study. Ann Trop Med Parasitol 1995;89:431-437.
46. el Guneid AM, Gunaid AA, O'Neill AM, Zureikat NI, Coleman JC, Murray-Lyon IM. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993;40:330-334.
47. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 1993;49:435-439.
48. Saleh MG, Pereira LM, Tibbs CJ, Ziu M, al Fituri MO, Williams R, McFarlane IG. High prevalence of hepatitis C virus in the normal Libyan population. Trans R Soc Trop Med Hyg 1994;88:292-294.
49. Delaporte E, Thiers V, Dazza MC, Romeo R, Mlika-Cabanne N, Aptel I, Schrijvers D, et al. High level of hepatitis C endemicity in Gabon, equatorial Africa. Trans R Soc Trop Med Hyg 1993;87:636-637.
50. Kowo MP, Goubau P, Ndam EC, Njoya O, Sasaki S, Seghers V, Kesteloot H. Prevalence of hepatitis C virus and other blood-borne viruses in Pygmies and neighboring Bantus in southern Cameroon. Trans R Coc Trop Med Hyg 1995;89:484-486.
51. Fingerhood MI, Jasinski DR, Sullivans JT. Prevalence of hepatitis C in a chemically dependent population. Arch Intern Med 1993;153:2025-2030.
52. Maayan S, Shufman EN, Engelhard D, Shouval D. Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem. Addiction 1994;89:869-874.
53. Van Ameijden EJ, van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993;9:255-262.
54. Woodfield DG, Harness M, Rix-Trott K. Hepatitis C virus infections in oral and injectable drug users. N Z Med J 1993;106:332-334
55. Mauser-Bunschoten EP, Bresters D, Van Drimmelen AA, Roosendaal G, Cuypers HT, Reesink HW, van der Poel CL, et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995;45:241-246.
56. Morfini M, Manucci PM, Ciavarella N, Schiavoni M, Gringeri A, Rafanelli D, Di Bona E, et al. Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation. Vox Sang 1994;67:178-182.
57. Soni PN, Tait DR, Kenoyer DG, Fernades-Costa F, Naicker S, Gopaul W, Simjee AE. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 1993;40: 65-68.
58. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, et al. A multicenter study of viral hepatitis in an United States hemophiliac population. Blood 1993;81:412-418.
59. Wagner N, Rotthauwe HW. Hepatitis C contributes to liver disease in children and adolescents with hemophilia. Klin Padiatr 1994;206:40-44.
60. Dorruci M, Pezotti P, Philipps AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study Group. J Infect Dis 1995;172: 1503-1508.
61. Quan MC, Krajden M, Grigoriew GA, Salit IE. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Inf Dis 1993;17:117-119.
62. Quaranta JF, Delaney SR, Allemann S, Cassuto JP, Dellamonica P, Allain JP. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients. J Med Virol 1994;42:29-32.
63. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drag users. J Infect Dis 1996;174:690-695.
64. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994;87:555-561.
65. Bukh J, Wantzin P, Krogsgaard K, Knudson F, Purcell RH, Miller RH, and the Copenhagen Dialysis HCV Study Group. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993;168:1343-1348.
66. Cassidy MJ, Jankelson D, Becker M, Dunne T, Walzl G, Moosa MR. The prevalence of antibodies to hepatitis C virus at two hemodialysis units in South Africa. S Afr Med J 1995;85:996-998.
67. Dussol B, Chicheportiche C, Cantaloube JJ, Roubicek C, Biagini P, Berthezene P, Berland Y. Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients. Am J Kidney Dis 1993; 2:574-580.
68. Lin DY, Lin HH, Huang CC, Liaw YK. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 1993;21:288-291.
69. Gladziwa U, Schlipkoter U, Lorbeer B, Cholmakow K, Roggendorf M, Sieberth HG. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis - a multicenter study. Clin Nephrol 1993;40:46-52.
70. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995;23:28-31.
71. Ban BK, Yang CW, Yoon SA, Kim YS, Chang YS, Koh YB. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients. Nephron 1995;70:397-401.
72. Genesca J, Vila J, Cordoba J, Sauleda S, Quer J, Esteban JI, Estaban R, et al. Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication. J Hepatol 1995;22:272-277.
73. Pereira BJG, Milford EL, Kirkman RL. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992;327:910-915.
74. Ilako FM, McLigeyo SO, Riyat MS, Lule GN, Okoth FA, Kaptich D. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J 1995;72:362-364.
75. Pouteil-Noble C, Tardy JC, Chossegros P, Mion F, Chevallier M, Gerard F, Chevallier P, et al. Co-infection by hepatitis B virus and hepatitis C viras in renal transplantation: morbidity and mortality in 1098 patients. Nephrol Dial Transplant 1995;10:122-124.
76. Coelho-Little M, Jeffers LJ, Bernstein DE, Goodman JJ, Reddy KR, de Medina M, Li X, et al. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. Alcohol Clin Exp Res 1995; 19:1173-1176.
77. Fong TL, Kanel GC, Conrad A, Valinluck B, Charboneau F. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. HEPATOLOGY 1994;19:554-557.
78. Gonzalez-Quintela A, Alende R, Aguilera A, Tome S, Gude F, Perez Becerra E, Torre A, et al. Hepatitis C virus antibodies in alcoholic patients. Rev Clin Esp 1995;195:367-372.
79. Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, et al. "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. HEPATOLOGY 1994;19:577-582.
80. Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Katayama K, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. HEPATOLOGY 1994;20:1115-1120.
81. Befrits R, Hedman M, Blomquist L. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterology 1995;30:1113-1118.
82. Verbaan H, Andersson K, Eriksson S. Intravenous drag abuse - the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterology 1993;28:714-718.
83. Mendenhall CL, Moritz T, Rouster S, Roselle G, Polito A, Quan S, diNelle RK. Epidemiology of hepatitis C among veterans with alcoholic liver disease. Am J Gastroenterol 1993;88:1022-1026.
84. Bode JC, Alscher DM, Wisser H, Bode C. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Alcohol alcohol 1995;30:97-103.
85. Thomas DL, Mahley RW, Badur S, Palaoglu E, Quinn TC. The epidemiology of hepatitis C in Turkey. Infection 1994;22:411-414.
86. Ducos J, Mondain AM, Perney P, Balavoine M, Zurek V, Petrukh Y, Pavlosky M, et al. Estimation of hepatitis C virus (HCV) prevalence in Lviv, Ukraine [Abstract]. HEPATOLOGY 1996;24:267A.
87. Kuperan P, Choon AT, Ding SH, Lee G. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore. Southeast Asian J Trop Med Public Health 1993;24:127-129.
88. Khan M, Husain M, Yano M, Hashizume K, Yousuf M, Tanaka E, Matsumoto A, et al. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan. Gastroenterology Jpn 1993;28:28-31.
89. Bar Shany S, Green MS, Slepon R, Shinar E. Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin. J Viral Hepatol 1995;2:139-144.
90. Fest T, de Wazieres B, Agis F, Viel JF, Gordien E, Dupond JL, Herve P. A unique seroepidemiologic situation for hepatitis B marker in Guadeloupe. Results of a prospective study in blood donors. Gatroenterol Clin Biol 1993;17:207-211.
91. Vasconcelos HC, Yoshida CF, Vanderborght BO, Schatzmayr HG. Hepatitis B and C prevalences among blood donors in the south region of Brazil. Mem Inst Oswalso Cruz 1994;89:503-507.
92. Develoux M, Boni G, Aguessy-Ahyi B, Gnahoui L, Delaporte E. The prevalence of anti-hepatitis C antibodies in pregnant women and blood donors in Benin. Bull Soc Pathol Exot 1995;88:115-116.
93. el Gohary A, Hassan A, Nooman Z, Lavanchy D, Mayerat C, el Ayat A, Fawaz N, et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 1995;59:155-161.
94. Sheu JC, Wang JT, Wang TH, Wang CY, Yang PM, Huang GT, Shih LN, et al. Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction. J Hepatol 1993;17:192-198.
95. Song P, Duc DD, Hien B, Nakata S, Chosa T, Watanabe J, Tsuda F, et al. Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clin Diagn Lab Immunol 1994;1:413-418.